Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Arix Bioscience plc
  6. News
  7. Summary
    ARIX   GB00BD045071

ARIX BIOSCIENCE PLC

(ARIX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Arix Bioscience : Appoints New Managing Director

07/06/2021 | 07:36am EDT


ę MT Newswires 2021
All news about ARIX BIOSCIENCE PLC
09/20PRESS RELEASE : Rentschler Biopharma appoints Dr. Christian Schetter as Chief Scientific O..
DJ
09/20ARIX BIOSCIENCE PLC(LSE : ARIX) added to S&P Global BMI Index
CI
09/03VC DAILY : Question: What Is Driving Startup -2-
DJ
09/02ARIX BIOSCIENCE : To Invest $11 Million In Disc Medicine
MT
09/02Arix Bioscience participates in USD90 million Series B financing for Disc Medicine
DJ
09/02Disc Medicine, Inc. announced that it has received $90 million in funding from a group ..
CI
09/01Total Voting Rights
DJ
08/31Transaction in own shares
DJ
08/16Transaction in own shares
DJ
08/16Director/PDMR Shareholding
DJ
More news
Financials
Sales 2021 0,50 M 0,68 M 0,68 M
Net income 2021 37,7 M 51,5 M 51,5 M
Net cash 2021 146 M 199 M 199 M
P/E ratio 2021 5,54x
Yield 2021 -
Capitalization 200 M 273 M 273 M
EV / Sales 2021 108x
EV / Sales 2022 88,4x
Nbr of Employees 12
Free-Float 72,2%
Chart ARIX BIOSCIENCE PLC
Duration : Period :
Arix Bioscience plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ARIX BIOSCIENCE PLC
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 160,00 GBX
Average target price 221,50 GBX
Spread / Average Target 38,4%
EPS Revisions
Managers and Directors
Robert William Henry Lyne CEO, COO, Secretary, Director & General Counsel
Marcus Karia Group Finance Director
Peregrine D. E. M. Moncreiffe Non-Executive Chairman
Graeme Smith Chief Technology Officer
Giles Francis Bertram Kerr Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
ARIX BIOSCIENCE PLC-26.94%274
INVESTOR AB (PUBL)32.08%70 090
CK HUTCHISON HOLDINGS LIMITED-5.27%25 684
HAL TRUST32.13%15 483
AB INDUSTRIVÄRDEN (PUBL)3.65%14 139
LIFCO AB (PUBL)61.60%13 384